Remepy, an Israeli startup, has successfully closed a $10 million Seed investment round led by NFX, with participation from other investors. The company's new hybrid drugs combine traditional drugs with 'digital molecules' to enhance their effectiveness.

97212 Ventures

Fresh.Fund

Tech Aviv

Firstime Ventures

Supernode Ventures

Psymed Ventures

Vine Ventures

Remepy is an Israeli startup that specializes in developing hybrid drugs combining traditional drugs with 'digital molecules' to enhance their effectiveness.

https://www.remepy.com/

Biotechnology

Ramat Gan

Remepy

Remepy raises $10 million in a Seed round led by NFX to bring first hybrid drug to market.

Remepy raises $10 million in a Seed round led by NFX to bring first hybrid drug to market.

Investors

Description

Company Information

Funding Insights

Related People

Remepy raises $10 million in a Seed round led by NFX to bring first hybrid drug to market.

Investors

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Related People

Company Information